References

Ahmed H, Davies F, Francis N, Farewell D, Butler C, Paranjothy S. Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: systematic review and meta-analysis of randomised trials. BMJ Open. 2017; 7:(5) https://doi.org/10.1136/bmjopen-2016-015233

Alanazi MQ. An evaluation of community-acquired urinary tract infection and appropriateness of treatment in an emergency department in Saudi Arabia. Ther Clin Risk Manag. 2018; 14:2363-2373 https://doi.org/10.2147/TCRM.S178855

Altarac S, Papeš D. Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU Int. 2014; 113:(1)9-10 https://doi.org/10.1111/bju.12492

Antoniou T, Gomes T, Juurlink DN, Loutfy MR, Glazier RH, Mamdani MM. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study. Arch Intern Med. 2010; 170:1045-1049 https://doi.org/10.1001/archinternmed.2010.142

Barclay J. Non-antibiotic options for recurrent urinary tract infections in women. Br Med J. 2017; 359 https://doi.org/10.1136/bmj.j5193

Bardsley A. Diagnosis, prevention and treatment of urinary tract infections in older people. Nurs Older People. 2017; 29:(2)32-38 https://doi.org/10.7748/nop.2017.e884

Benton TJ, Young RB, Leeper SC. Asymptomatic bacteriuria in the nursing home. Ann Longterm Care. 2006; 14:(7)17-22

Beveridge LA, Davey PG, Phillips G, McMurdo ME. Optimal management of urinary tract infections in older people. Clin Interv Aging. 2011; 6:173-80 https://doi.org/10.2147/CIA.S13423

Bouckaert J, Berglund J, Schembri M Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol. 2005; 55:(2)441-455 https://doi.org/10.1111/j.1365-2958.2004.04415.x

Cai T, Koves B, Johansen TE. Asymptomatic bacteriuria, to screen or not to screen – and when to treat?. Curr Opin Urol. 2017; 27:(2)107-111 https://doi.org/10.1097/MOU.0000000000000368

Cusumano C, Pinker J, Han Z Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med. 2011; 3:(109)109-115 https://doi.org/10.1126/scitranslmed.3003021

Detweiler K, Mayers D, Fletcher SG. Bacteruria and urinary tract infections in the elderly. Urol Clin North Am. 2015; 42:(4)561-568 https://doi.org/10.1016/j.ucl.2015.07.002

Dimitrov TS, Udo EE, Awni F, Emara M, Passadilla R. Etiology and antibiotic susceptibility patterns of community-acquired urinary tract infections in a Kuwait hospital. Med Princ Pract. 2004; 13:(6)334-339 https://doi.org/10.1159/000080470

Domenici L, Monti M, Bracchi C D-mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci. 2016; 20:(13)2920-2925

Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015; 13:(5)269-284 https://doi.org/10.1038/nrmicro3432

Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002; 113:5S-13S

Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010; 7:(12)653-660 https://doi.org/10.1038/nrurol.2010.190

Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014; 28:(1)1-13 https://doi.org/10.1016/j.idc.2013.09.003

George CE, Norman G, Ramana GV, Mukherjee D, Rao T. Treatment of uncomplicated symptomatic urinary tract infections: resistance patterns and misuse of antibiotics. J Fam Med Prim Care. 2015; 4:(3)416-421 https://doi.org/10.4103/2249-4863.161342

Gopal Rao G, Patel M. Urinary tract infection in hospitalized elderly patients in the United Kingdom: the importance of making an accurate diagnosis in the post broad-spectrum antibiotic era. J Antimicrob Chemother. 2009; 63:(1)5-6 https://doi.org/10.1093/jac/dkn458

Gupta K, Trautner B. Diagnosis and management of recurrent urinary tract infections in non-pregnant women. Br Med J. 2013; 346 https://doi.org/10.1136/bmj.f3140

Hillier S, Roberts Z, Dunstan F, Butler C, Howard A, Palmer S. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother. 2007; 60:(1)92-99 https://doi.org/10.1093/jac/dkm141

Hooton TM. Pathogenesis of urinary tract infections: an update. J Antimicrob Chemother. 2000; 46:1-7

Hung CS, Bouckaert J, Hung D Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol. 2002; 44:(4)903-915

Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012; 10 https://doi.org/10.1002/14651858.CD001321.pub5

Juthani-Mehta M, Quagliarello V, Perrelli E Clinical features to identify urinary tract infections in nursing home residents: a cohort study. J Am Geriatr Soc. 2009; 57:963-970 https://doi.org/10.1111/j.1532-5415.2009.02227.x

Kelly-Fatemi B. Urinary tract infection: management in elderly patients. Pharm J. 2015; 295

Klemm P, Roos V, Ulett GC, Svanborg C, Schembri MA. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun. 2006; 74:(1)781-785 https://doi.org/10.1128/IAI.74.1.781-785.2006

Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014; 32:(1)79-84 https://doi.org/10.1007/s00345-013-1091-6

Lim CJ, Kong DC, Stuart RL. Reducing inappropriate antibiotic prescribing in the residential care setting: current perspectives. Clin Interv Aging. 2014; 9:165-177 https://doi.org/10.2147/CIA.S46058

Matthews J, Lancaster J. Urinary tract infections in the elderly population. Am J Geriatr Pharmacother. 2011; 9:(5)286-309 https://doi.org/10.1016/j.amjopharm.2011.07.002

McClean P, Tunney M, Gilpin D, Parsons C, Hughes C. Antimicrobial prescribing in nursing homes in Northern Ireland: results of two point-prevalence surveys. Drugs Aging. 2011; 28:(10)819-829 https://doi.org/10.2165/11595050-000000000-00000

McClean P, Tunney M, Gilpin D, Parsons C, Hughes C. Antimicrobial prescribing in residential homes. J Antimicrob Chemother. 2012; 67:(7)1781-1790 https://doi.org/10.1093/jac/dks085

Micali S, Isgro G, Bianchi G, Miceli N, Calapai G, Navarra M. Cranberry and recurrent cystitis: more than marketing?. Crit Rev Food Sci Nutr. 2014; 54:(8)1063-1075 https://doi.org/10.1080/10408398.2011.625574

McMurdo ME, Gillespie ND. Urinary tract infection in old age: over-diagnosed and over-treated. Age Ageing. 2000; 29:297-298

Melekos MD, Naber KG. Complicated urinary tract infections. Int J Antimicrob Agents. 2000; 15:(4)247-256 https://doi.org/10.1016/S0924-8579(00)00168-0

National Institute for Health and Care Excellence. Urinary tract infection (lower)— women. 2015. http://tinyurl.com/kpqm64o (accessed 20 February 2019)

National Institute for Health and Care Excellence. Urinary tract infection (lower): antimicrobial prescribing. NG109. 2018a. http://tinyurl.com/ya39ksgb (accessed 2 February 2019)

National Institute for Health and Care Excellence. Urinary tract infection (recurrent): antimicrobial prescribing. NG112. 2018b. http://tinyurl.com/ya74guo6 (accessed 1 February 2019)

Ninan S, Walton C, Barlow G. Investigation of suspected urinary tract infection in older people. Br Med J. 2014; 349 https://doi.org/10.1136/bmj.g4070

Omigie O, Okoror L, Umolu P, Ikuuh G. Increasing resistance to quinolones: a four-year prospective study of urinary tract infection pathogens. Int J Gen Med. 2009; 2:171-175

Prakash D, Saxena RS. Prevalence and antimicrobial susceptibility pattern of Escherichia coli in hospital acquired and community acquired patients related to urinary tract infection in India. J Appl Pharma Sci. 2013; 3:(8)124-132 https://doi.org/10.7324/JAPS.2013.3822

Porru D, Parmigiani A, Tinelli C Oral D-mannose in recurrent urinary tract infections in women: a pilot study. J Clin Urol. 2014; 7:(3)208-213 https://doi.org/10.1177/2051415813518332

Roos V, Ulett GC, Schembri MA, Klemm P. The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun. 2006; 74:(1)615-624 https://doi.org/10.1128/IAI.74.1.615-624.2006

Salvatore S, Salvatore S, Cattoni E Urinary tract infections in women. Eur J Obstet Gynecol Reprod Biol. 2011; 156:(2)131-136 https://doi.org/10.1016/j.ejogrb.2011.01.028

Shigemura K, Tanaka K, Okada H Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983-2002) at a single institution in Japan. Jpn J Infect Dis. 2005; 58:(5)303-308

Schwartz DJ, Kalas V, Pinkner J Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci U S A. 2013; 110:(39)15530-15537 https://doi.org/10.1073/pnas.1315203110

Vicariotto F. Effectiveness of an association of a cranberry dry extract, D-mannose, and the two microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in women affected by cystitis: a pilot study. J Clin Gastroenterol. 2014; 48:S96-S101 https://doi.org/10.1097/MCG.0000000000000224

Walker S, McGeer A, Simor AE, Armstrong-Evans M, Loeb M. Why are antibiotics prescribed for asymptomatic bacteriuria in institutionalized elderly people?: a qualitative study of physicians' and nurses' perceptions. Can Med Assoc J. 2000; 163:(3)273-277

While A. ‘No action today means no cure tomorrow’: the threat of antimicrobial resistance. Br J Community Nurs. 2016; 21:(7)344-347 https://doi.org/10.12968/bjcn.2016.21.7.344

Wilson L, Brown JS, Shin GP, Luc KO, Subak LL. Annual direct cost of urinary incontinence. Obstet Gynecol. 2001; 98:(3)398-406

Woodford HJ, George J. Diagnosis and management of urinary tract infection in hospitalized older people. J Am Geriatr Soc. 2009; 57:(1)107-114 https://doi.org/10.1111/j.1532-5415.2008.02073.x

Zalmanovici Trestioreanu A, Lador A, Sauerbrun-Cutler M, Leibovici L. Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev. 2015; 4 https://doi.org/10.1002/14651858.CD009534.pub2

Alternative to antibiotics for managing asymptomatic and non-symptomatic bacteriuria in older persons: a review

02 March 2019
Volume 24 · Issue 3

Abstract

Recurrent urinary tract infection (UTI) is one of the most common reasons for long-term antibiotic use in frail older people, and these individuals often have non-symptomatic bacteriuria. This article reviews the literature and recommendations for the treatment of UTIs particularly in the older population (>65 years). It considers the question: is there an alternative for antibiotics for asymptomatic and non-symptomatic bacteriuria in older adults? D-mannose powder has been recommended for the treatment of UTIs, as when applied locally, it reduces the adherence of Escherichia coli. In one study, D-mannose was reviewed for the prophylaxis of recurrent UTIs in women, and the findings indicated that it may be useful for UTI prevention instead of prophylactic antibiotics. There is a lack of information about the efficacy of cranberry products combined with D-mannose in this regard, and this is an area for further research.

This article is a review of the literature and recommendations for the treatment of urinary tract infections (UTIs) in the older population (those over 65 years old). The topic discussed is particularly of interest for healthcare professionals working in the community setting, as the cohort of individuals aged over 65 years is known to be prescribed unnecessary antibiotic treatment for asymptomatic bacteriuria (ABU) (NICE, 2018a). Recurrent UTI is also one of the most common reasons for long-term antibiotic use in frail older adults (McClean et al, 2011; 2012; NICE, 2018b). This study asks the question: is there an alternative to antibiotics for ABU and non-symptomatic bacteriuria in older adults? It also explores the recent focus on D-mannose for the prophylaxis and treatment of ABU and recurrent UTIs.

Register now to continue reading

Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month